Andere talen Physiomics Plc

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:19 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,3 ^GBX	-3,70%		-16,13%	-18,75%

03/05	Physiomics waarschuwt dat grote contracten langer op zich laten wachten dan verwacht	AN
03/05	AIM WINNAARS EN VERLIEZERS: Fletcher King optimistisch; Angle in Astra-deal	AN

Physiomics warns large contracts taken longer than expected	03/05
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	03/05
Physiomics Plc Increases Revenue Expectation for the Year 2025	03/05
Physiomics Plc Provides Earnings Guidance for the Financial Year Ending 30 June 2024	03/05
Physiomics celebrates "substantial" contract with old client	18/03
Physiomics Wins DNA-related Modeling Contract with Large Pharmaceutical Company	18/03
Physiomics plc Wins Contract by an Existing Pharma Client	18/03
Physiomics reports higher interim revenue; loss narrows	07/03
Physiomics Plc Reports Earnings Results for the Half Year Ended December 31, 2023	07/03
Physiomics celebrates contract award for cancer therapy insect model	19/02
The University of Sheffield Selects Physiomics plc to Support a Grant funded Project Focused on an Insect (Fruit Fly) Model of Cancer Treatment	19/02
Physiomics wins deal to support client's oncology assets	05/02
Physiomics plc Announces Contract Award	05/02
Physiomics appoints COO Sargent as new CEO; completes restructuring	22/01
Physiomics Names CEO as Nonexecutive Chairman	22/01
Physiomics Names CEO as Chairman	22/01
Physiomics plc Announces Chief Executive Officer Changes	22/01
Physiomics plc Announces Executive Changes	22/01
ValiRx Plc - ValiRx 2023, a year in review	20/12
Physiomics Secures Grant to Advance Personalized Chemotherapy Tool in UK	10/11

Geen resultaten voor deze zoekopdracht